Please login to the form below
Spain
This page shows the latest Spain news and features for those working in and with pharma, biotech and healthcare.
EC approves Roche’s Tecentriq for early-stage lung cancer
Enriqueta Felip, Head of the Thoracic Cancer Unit at Vall d’Hebron Institute of Oncology, Barcelona, Spain.
Latest news
-
Pfizer/BioNTech COVID-19 vaccine produces strong immune response in children
Poland and Spain.
-
NICE recommends long-acting HIV therapy developed by ViiV Healthcare and Janssen
The drug combination was approved in Europe in December 2020 and was welcomed by Dr Antonio Antela from University Hospital, Santiago de Compostela, Spain.
-
Benefits of COVID-19 vaccine in younger children outweigh risks, says FDA
in the US, Finland, Poland and Spain.
-
Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination
Researchers evaluated blood samples from 322 participants 28-90 days after their last COVID-19 vaccine dose using data from the MS PATHS network in the US, Germany and Spain.
-
AZ buys Caelum Biosciences for $500m
Around 20, 000 people across the US, France, Germany, Italy, Spain and the UK live with AL amyloidosis classified as Mayo stage IIIa or IIIb disease.
More from news
Approximately 10 fully matching, plus 368 partially matching documents found.
Latest Intelligence
-
Health technology assessments: understanding the global landscape and considerations for drug development
Cost- effectiveness assessments have more recently been implemented in France as part of the Haute Autorité de Santé’s (HAS) evaluation of highly innovative treatments, and payers in Spain are considering
-
Pharma’s authentic proof of purpose influences decisions among HCPs and payers
Those in France and Spain aligned their purpose more to ensuring efficiency and cost- effectiveness of care.
-
Understand, identify and partner with HCPs to improve patient support
Such as a post from Ana Piera, a doctor in Spain, who uses an image from World Diabetes Day and linked to an important topic of the day – that many diabetes
-
Unlocking the potential of precision medicine in oncology
For me, it’s a very personal challenge. Devastatingly, my father passed away this year due to cancer during the peak of the coronavirus pandemic in Spain.
-
The flexible salesforce
In Spain, other channels went from 12% of total activity in January to 94% in May, Italy 9% to 96% and Brazil 15% to 89% (Figure 2). ... In Spain the baseline was 4% of total promotional activity in January, rising to 49% in May and remaining at 38% in
More from intelligence
Approximately 2 fully matching, plus 54 partially matching documents found.
Latest appointments
-
STEM Healthcare bolsters its EU5 team
Enrique Cruz-Jentoft (pictured right) has joined the agency as its general manager for Spain following pharmaceutical industry experience gained from servingand MSD.
-
Minoryx Therapeutics adds to board of directors
Dr Claude Nicaise joins as an independent board member. Dr Claude Nicaise has joined Barcelona, Spain-based Minoryx Therapeutics as an independent board member.
-
Caldan Therapeutics bolsters senior team
Most recently, Dr Connolly served as scientific leader with Almirall, based in Barcelona, Spain.
-
ClinTec appoints regional manager for Spain and Portugal
Carlos Palacios joins the contract research organisation. Contract research organisation ClinTec International has appointed Carlos Palacios to the newly-created position of regional manager for Spain and Portugal. ... Palacios joins ClinTec from Merck,
-
Sonia Ruiz Moran appointed president of EMVO
She comes to the EMVO with a wealth of pharma experience, having led European Public Affairs at the General Pharmaceutical Council of Spain, since 2008. ... Prior to joining the General Pharmaceutical Council of Spain, Ruiz Moran worked at Prisa, a
More from appointments
Approximately 1 fully matching, plus 18 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
LactApp is a breastfeeding companion app which was designed in Spain and is now used by 19% of Spanish new mothers.
-
What does the future hold for clinical trial recruitment?
For example, in Spain direct approaches through social media are prohibited whereas in the UK and US this is permissible.
-
Viseven opens a new center of excellence in India
Presently, the company has specialists in more than ten countries, including the United States, Canada, Argentina, France, Spain, Germany, Poland, and Ukraine.
-
How do doctors want to engage with pharma on new products?
M3 Global Research put these questions to 1, 848 EU doctors mainly from the top five EU nations – Germany (332); France (380); Italy (266); Spain (293) and UK (318).
-
What does the future hold for Light-chain Amyloidosis?
According to recent reports, approximately 20, 000 people across the US, France, Germany, Italy, Spain and the UK live with AL amyloidosis, classified as Mayo stage IIIa or IIIb.
More from PMHub
Approximately 0 fully matching, plus 53 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
PMHub
11 London
We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
